Hypertension and orthostatic hypotension with venlafaxine treatment in depressed older adults

Autor: Jordan F. Karp, Marcos Sanches, Benoit H. Mulsant, Rafae Wathra, Kyle W Goldberger, Charles F. Reynolds, Lauren Thomson, Eric J. Lenze, Daniel M. Blumberger
Rok vydání: 2020
Předmět:
Zdroj: J Psychopharmacol
ISSN: 1461-7285
0269-8811
DOI: 10.1177/0269881120944154
Popis: Background: Venlafaxine, a serotonin–norepinephrine reuptake inhibitor, is often used as first- or second-line therapy for depression in older adults. It can be associated with adverse blood pressure (BP) effects. Methods: Adults ⩾60 years of age in a current major depressive episode were treated in a protocolized manner with venlafaxine XR; 429 participants were treated for 8–16 weeks with a daily dose up to 300 mg to achieve remission from depression. Cardiac measures included sitting and standing BP and heart rate. Results: Of participants who were normotensive at baseline, 6.5% were found to have elevated BP during the study (1.9% Conclusion: A large proportion of older adults treated with venlafaxine experience orthostatic hypotension, putting them at risk for falls. A smaller proportion experience elevated BP. Older patients prescribed venlafaxine, particularly at high doses, should be advised and counseled about these adverse effects.
Databáze: OpenAIRE